175 related articles for article (PubMed ID: 31393011)
1. Pregnant women with confirmed neoplasms should not have noninvasive prenatal testing.
Lenaerts L; Van Calsteren K; Che H; Vermeesch JR; Amant F
Prenat Diagn; 2019 Nov; 39(12):1162-1165. PubMed ID: 31393011
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive prenatal testing: from aneuploidy to single genes.
Guseh SH
Hum Genet; 2020 Sep; 139(9):1141-1148. PubMed ID: 31555907
[TBL] [Abstract][Full Text] [Related]
3. Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing.
Amant F; Verheecke M; Wlodarska I; Dehaspe L; Brady P; Brison N; Van Den Bogaert K; Dierickx D; Vandecaveye V; Tousseyn T; Moerman P; Vanderstichele A; Vergote I; Neven P; Berteloot P; Putseys K; Danneels L; Vandenberghe P; Legius E; Vermeesch JR
JAMA Oncol; 2015 Sep; 1(6):814-9. PubMed ID: 26355862
[TBL] [Abstract][Full Text] [Related]
4. Nonreportable rates and cell-free DNA profiles in noninvasive prenatal testing among women with heparin treatment.
Nakamura N; Sasaki A; Mikami M; Nishiyama M; Akaishi R; Wada S; Ozawa N; Sago H
Prenat Diagn; 2020 Jun; 40(7):838-845. PubMed ID: 32274797
[TBL] [Abstract][Full Text] [Related]
5. Most noninvasive prenatal screens failing due to inadequate fetal cell free DNA are negative for trisomy when repeated.
Lopes JL; Lopes GS; Enninga EAL; Kearney HM; Hoppman NL; Rowsey RA
Prenat Diagn; 2020 Jun; 40(7):831-837. PubMed ID: 32274800
[TBL] [Abstract][Full Text] [Related]
6. Sequencing of Circulating Cell-free DNA during Pregnancy.
Bianchi DW; Chiu RWK
N Engl J Med; 2018 Aug; 379(5):464-473. PubMed ID: 30067923
[TBL] [Abstract][Full Text] [Related]
7. Causes of aberrant non-invasive prenatal testing for aneuploidy: A systematic review.
Samura O; Okamoto A
Taiwan J Obstet Gynecol; 2020 Jan; 59(1):16-20. PubMed ID: 32039788
[TBL] [Abstract][Full Text] [Related]
8. Correlation between Z score, fetal fraction, and sequencing reads in non-invasive prenatal testing.
Balslev-Harder M; Richter SR; Kjaergaard S; Johansen P
Prenat Diagn; 2017 Sep; 37(9):943-945. PubMed ID: 28726258
[No Abstract] [Full Text] [Related]
9. Prenatal testing can detect occult cancer in pregnant women.
Tanday S
Lancet Oncol; 2015 Aug; 16(8):e383. PubMed ID: 26190750
[No Abstract] [Full Text] [Related]
10. Incidental Detection of Maternal Neoplasia in Noninvasive Prenatal Testing.
Dharajiya NG; Grosu DS; Farkas DH; McCullough RM; Almasri E; Sun Y; Kim SK; Jensen TJ; Saldivar JS; Topol EJ; van den Boom D; Ehrich M
Clin Chem; 2018 Feb; 64(2):329-335. PubMed ID: 28982650
[TBL] [Abstract][Full Text] [Related]
11. [Utterly unanticipated findings].
Jordan B
Med Sci (Paris); 2015 May; 31(5):567-8. PubMed ID: 26059309
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive Prenatal Diagnosis of Single-Gene Disorders by Use of Droplet Digital PCR.
Camunas-Soler J; Lee H; Hudgins L; Hintz SR; Blumenfeld YJ; El-Sayed YY; Quake SR
Clin Chem; 2018 Feb; 64(2):336-345. PubMed ID: 29097507
[TBL] [Abstract][Full Text] [Related]
13. Cell-free DNA screening for fetal aneuploidy using the rolling circle method: A step towards non invasive prenatal testing simplification.
Pavanello E; Sciarrone A; Guaraldo V; Muccinelli E; Ciuffreda VP; Sauro P; Bondielli G; Mirante S; Mengozzi G; Viora E; Cuckle H; Pasini B
Prenat Diagn; 2021 Dec; 41(13):1694-1700. PubMed ID: 34569636
[TBL] [Abstract][Full Text] [Related]
14. The Setup and Application of Reference Material in Sequencing-Based Noninvasive Prenatal Testing.
Qu S; Zhang Y; Yang X; Tan Y; Li M; Yang X; Zhou L; Chen D; Chen Y; Yan M; Wang Q; Yu T; Sun N; Jiang H; Su F; Di Y; Lin G; Yuan Y; Chen F; Mu F; Huang J
Gynecol Obstet Invest; 2021; 86(1-2):123-131. PubMed ID: 33784691
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics Pipeline for Accurate Quantification of Fetal DNA Fraction in Maternal Plasma.
Ni M; Peng XL; Jiang P
Methods Mol Biol; 2019; 1909():177-180. PubMed ID: 30580431
[TBL] [Abstract][Full Text] [Related]
16. Rate of no result in cell-free DNA testing and its influence on test performance metrics.
Grati FR; Kagan KO
Ultrasound Obstet Gynecol; 2017 Jul; 50(1):134-137. PubMed ID: 27731527
[No Abstract] [Full Text] [Related]
17. The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation.
Cai YH; Yao GY; Chen LJ; Gan HY; Ye CS; Yang XX
DNA Cell Biol; 2018 Jul; 37(7):626-633. PubMed ID: 29957029
[TBL] [Abstract][Full Text] [Related]
18. Maternal chromosome Xp deletion identified by prenatal cell-free DNA screening.
Ilagan BJ; Maxwell MD; Fisher BM; Milanovich J; Owen R; Anderson B; Zhang K; Strom CM
Prenat Diagn; 2017 Sep; 37(9):935-937. PubMed ID: 28654736
[No Abstract] [Full Text] [Related]
19. Reducing false positive rate of fetal monosomy X in non-invasive prenatal testing using a combined algorithm to detect maternal mosaic monosomy X.
Phan MD; Vo BT; Nguyen TV; Tran NT; Trinh HNT; Nguyen TTQ; Nguyen NH; Tran TT; Tran UV; Dao TTH; Pham AH; Tran TH; Truong KD; Hoang TTD; Do TT; Nguyen HN; Giang H
Prenat Diagn; 2019 Mar; 39(4):324-327. PubMed ID: 30719744
[No Abstract] [Full Text] [Related]
20. Genome-wide detection of additional fetal chromosomal abnormalities by cell-free DNA testing of 15,626 consecutive pregnant women.
Yao H; Gao Y; Zhao J; Zhang R; Xu H; Hu H; Luo Y; Yuan Y; Fu M; Zhang H; Jiang H; Wang W; Yang H; Wang J; Liang Z; Chen F
Sci China Life Sci; 2019 Feb; 62(2):215-224. PubMed ID: 30076564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
